Summary
This 8-K filing from QUALCOMM INC/DE (QCOM) on June 8, 2005, primarily announces significant changes to its Board of Directors and executive leadership. Notably, Donald G. Cruickshank has been appointed to the Board of Directors, receiving a stock option grant of 40,000 shares. Additionally, Dr. Paul E. Jacobs is set to become the new Chief Executive Officer effective July 1, 2005, succeeding his father, Dr. Irwin Jacobs, who will remain as Chairman of the Board. Investors should note the strategic importance of these appointments as the company transitions leadership. The filing also provides details on stock option grants to new directors and outlines executive compensation previously disclosed, including compensation for Dr. Irwin Jacobs and his son, Jeffrey A. Jacobs, who serves as President, Global Development. The compensation practices and option grants appear to align with standard company policies for individuals at similar levels of responsibility.
Key Highlights
- 1Donald G. Cruickshank appointed to the Board of Directors, effective June 3, 2005.
- 2Mr. Cruickshank received a stock option grant for 40,000 shares at an exercise price of $38.25.
- 3Dr. Paul E. Jacobs appointed to the Board of Directors, effective June 2, 2005.
- 4Dr. Paul E. Jacobs will assume the role of Chief Executive Officer on July 1, 2005.
- 5Dr. Paul E. Jacobs is the son of Dr. Irwin Jacobs (current Chairman and CEO).
- 6Information on compensation and stock option grants for Dr. Irwin Jacobs and Jeffrey A. Jacobs (President, Global Development) is referenced from a prior proxy statement.
- 7The company is adhering to standard compensation practices for its employees and directors.